These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29498020)

  • 1. Botulinum Toxin: Does it have a Place in the Management of Depression?
    Rudorfer MV
    CNS Drugs; 2018 Feb; 32(2):97-100. PubMed ID: 29498020
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin therapy of bipolar depression: A case series.
    Finzi E; Kels L; Axelowitz J; Shaver B; Eberlein C; Krueger TH; Wollmer MA
    J Psychiatr Res; 2018 Sep; 104():55-57. PubMed ID: 29982082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipruritic Effects of Botulinum Neurotoxins.
    Gazerani P
    Toxins (Basel); 2018 Mar; 10(4):. PubMed ID: 29596343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New neurotoxins on the horizon.
    Freeman SR; Cohen JL
    Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin: a novel therapy for clozapine-induced sialorrhoea.
    Verma R; Anand KS
    Psychopharmacology (Berl); 2018 Jan; 235(1):369-371. PubMed ID: 29196826
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin in management of synkinesis in patients with unilateral and bilateral vocal fold paralysis.
    Lewis S; Woo P
    Laryngoscope; 2018 Feb; 128(2):447-450. PubMed ID: 28850724
    [No Abstract]   [Full Text] [Related]  

  • 7. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
    Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of multiple periocular eccrine hidrocystomata: is botulinum toxin or electrocautery more effective?
    Meys R; Perrett CM
    Clin Exp Dermatol; 2015 Jan; 40(1):101-3. PubMed ID: 25495674
    [No Abstract]   [Full Text] [Related]  

  • 9. Noncosmetic uses of botulinum toxin in otolaryngology.
    Benninger MS; Smith LJ
    Cleve Clin J Med; 2015 Nov; 82(11):729-32. PubMed ID: 26540323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Botulinum Toxin and Progressive Pneumoperitoneum Are Useful in the Treatment of Large Incisional Hernias.
    Bueno Lledó J; Torregrosa-Gallud A
    Am Surg; 2019 Apr; 85(4):e189-e192. PubMed ID: 31043210
    [No Abstract]   [Full Text] [Related]  

  • 11. Miller-Fisher Syndrome With Botulism Toxin Ingestion: The Ultimate Descending Paralysis.
    Hargis MJ; Howdeshell M
    J Clin Neuromuscul Dis; 2018 Mar; 19(3):146. PubMed ID: 29465619
    [No Abstract]   [Full Text] [Related]  

  • 12. The Use of Neurotoxins in the Male Face.
    Jones IT; Fabi SG
    Dermatol Clin; 2018 Jan; 36(1):29-42. PubMed ID: 29108543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review.
    Dhawan A; Dhawan S; Vitarella D
    J Drugs Dermatol; 2018 Sep; 17(9):956-958. PubMed ID: 30235381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins.
    Davletov B; Bajohrs M; Binz T
    Trends Neurosci; 2005 Aug; 28(8):446-52. PubMed ID: 15979165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False vocal cord botulinum toxin injection for refractory muscle tension dysphonia: Our experience with seven patients.
    Pacheco PC; Karatayli-Ozgursoy S; Best S; Hillel A; Akst L
    Clin Otolaryngol; 2015 Feb; 40(1):60-4. PubMed ID: 25314339
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin therapy: functional silencing of salivary disorders.
    Lovato A; Restivo DA; Ottaviano G; Marioni G; Marchese-Ragona R
    Acta Otorhinolaryngol Ital; 2017 Apr; 37(2):168-171. PubMed ID: 28516981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridial neurotoxins: from toxins to therapeutic tools?
    Niemann H; Binz T; Grebenstein O; Kurazono H; Thierer J; Mochida S; Poulain B; Tauc L
    Behring Inst Mitt; 1991 Jul; (89):153-62. PubMed ID: 1930094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum neurotoxin A in ophthalmology.
    Bentley C
    Ophthalmic Physiol Opt; 1996 Mar; 16 Suppl 1():S9-14. PubMed ID: 8796194
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of botulinum neurotoxin in pain management--an ongoing controversy.
    Ashkenazi A
    Curr Pain Headache Rep; 2009 Aug; 13(4):249-52. PubMed ID: 19586585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.